bioRxivMicrobiologyPreprint
Targeted degradation of SARS-CoV-2 via the autophagy-lysosome system using chemical mimetics of the N-degron pathway
Gee Eun LeeiD, Tae Hyun Bae, Uni ParkiD, Jihoon LeeiD, Dong Won Lee, Young Jo Song, Se Hun GuiD, Chi Ho Yu, Min‐Soo KimiD, Luis Martínez‐SobridoiD, Murim ChoiiD, Jun-Gyu Park, Nam‐Hyuk ChoiD, Yong Tae KwoniD, Ki Woon SungiD
Abstract
In the N-degron pathway, ATE1 transfers the amino acid L-arginine (L-Arg) from Arg-tRNAArg to N-terminal (Nt) residues of cellular proteins. The resulting Arg/N-degrons bind the autophagic receptor p62/SQSTSM-1/Sequestosome-1 to induce lysosomal degradation of various biomaterials. Here, we demonstrate that the chemical mimetics of Arg/N-degrons, termed autophagy-targeting ligands (ATLs), can induce lysosomal degradation of SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) via p62-mediated macroautophagy. In Vero E6 cells infected with SARS-CoV-2, ATLs promoted p62 self-polymerization and enhanced LC3 synthesis and lipidation, leading to viral sequestration within autophagosomes for lysosomal degradation. In transgenic mice overexpressing human angiotensin-converting enzyme 2 (ACE2), oral administration of ATL1014 inhibited viral replication and increased viability. In a Syrian hamster model, ATL1014 attenuated viral replication in the lungs and demonstrated efficacy in inflammatory lesions and pulmonary congestions. These results identify the N-degron pathway as a potential target for a host-targeting strategy (HTS) against a broad spectrum of viruses.
- organism: human
- organism: mouse
- organism: rat
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Protein arginylation is regulated during SARS-CoV-2 infection
J. Macedo-da-Silva, L. Rosa-Fernandes, … G. Palmisano·bioRxiv·Nov 2, 2021
- GNS561 exhibits potent in vitro antiviral activity against SARS-CoV-2 through autophagy inhibition
P. Halfon, E. Bestion, … R. F. Schinazi·bioRxiv·Oct 6, 2020
- Analysis of SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics
N. C. Gassen, J. Papies, … M. A. Muller·bioRxiv·Apr 15, 2020
- Losartan promotes cell survival following SARS-CoV-2 infection in vitro
R. Nejat, A. S. Sadr, … D. J. Najafi·bioRxiv·Dec 27, 2020
- The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators
K. Gorshkov, C. Z. Chen, … W. Zheng·bioRxiv·May 16, 2020
- Redirection of SARS-CoV-2 to Phagocytes by Intranasal sACE2-Fc as a Universal Decoy Confers Complete Prophylactic Protection
Jingyi Wang, Jiamei Li, … Bo Feng·bioRxiv·Sep 23, 2025